Study guide
8.3 Parametric vs. Non-Parametric Tests
AHIMA Certified Health Data Analyst CHDA
Track your progress as you read
Finished sections get a check mark.
1 Introduction & CHDA Exam Overview
0.1 About the AHIMA CHDA Exam 0.2 How to Use This Study Guide
2 Chapter 1: Healthcare Delivery Systems & Revenue Cycle
1.1 Healthcare Delivery Settings & Organizational Structures 1.2 Healthcare Revenue Cycle Management & Reimbursement Models 1.3 Regulatory Reporting & Accreditation Agencies
3 Chapter 2: Health Informatics, Datasets & AI
2.1 Electronic Health Records (EHR) & Health Informatics Foundations 2.2 Healthcare Datasets, Benchmarks & Population Health 2.3 Analytics Hierarchy & Artificial Intelligence in Healthcare
4 Chapter 3: Clinical Terminologies, Classifications & Standards
3.1 Clinical Classification Systems: ICD-10-CM/PCS & CPT/HCPCS 3.2 Clinical Terminologies & Ontologies: SNOMED CT, LOINC & RxNorm 3.3 Interoperability & Data Exchange Standards: HL7 v2, CDA & FHIR
5 Chapter 4: Business Needs Assessment & Scoping
4.1 Stakeholder Engagement & Analytics Needs Elicitation 4.2 Defining Metrics, KPIs & Healthcare Value 4.3 Analytics Project Management & Analysis Planning
6 Chapter 5: Data Sourcing, Lineage & Collection Methods
5.1 Healthcare Data Sourcing & Lineage 5.2 Healthcare Data Collection Methods & Architectures 5.3 Clinical & Financial Data Extraction
7 Chapter 6: Data Cleansing, Transformation & Validation
6.1 Healthcare Data Quality Assessment 6.2 Data Cleansing & Anomaly Remediation 6.3 Data Transformation, Mapping & Validation
8 Chapter 7: Exploratory Data Analysis & Descriptive Statistics
7.1 Healthcare Data Types & Scales of Measurement 7.2 Measures of Central Tendency & Dispersion 7.3 Exploratory Data Analysis in Clinical Populations
9 Chapter 8: Inferential Statistics & Hypothesis Testing
8.1 Sampling Techniques & Probability in Healthcare 8.2 Hypothesis Testing Fundamentals 8.3 Parametric vs. Non-Parametric Tests
10 Chapter 9: Advanced Statistical Modeling & Risk Adjustment
9.1 Correlation & Regression Analysis 9.2 Risk Adjustment & Healthcare Severity Modeling 9.3 Survival Analysis & Model Evaluation
11 Chapter 10: Healthcare Epidemiology & Study Methodologies
10.1 Epidemiological Measures of Disease Frequency & Association 10.2 Healthcare Study Designs & Methodologies 10.3 Confounding, Bias & Health Equity Analytics
12 Chapter 11: Healthcare Data Visualization & Dashboard Design
11.1 Principles of Effective Healthcare Data Visualization 11.2 Selecting Appropriate Healthcare Visualizations 11.3 Executive & Clinical Dashboard Architecture
13 Chapter 12: Healthcare Performance Measurement & CMS Quality Programs
12.1 CMS Quality Programs & Value-Based Purchasing 12.2 Clinical Quality Measures & Benchmarking 12.3 Financial Analytics & Case Mix Index Analysis
14 Chapter 13: Communicating Insights & Narrative Analytics
13.1 Translating Complex Analytics for Diverse Audiences 13.2 Contextualizing Limitations, Assumptions & Uncertainty 13.3 Narrative Reporting & Data-Driven Decision Support
15 Chapter 14: Healthcare Data Governance Frameworks & Stewardship
14.1 Enterprise Data Governance Frameworks 14.2 Data Stewardship & Master Patient Index (MPI) Management 14.3 Metadata Management & Business Glossaries
16 Chapter 15: Healthcare Privacy, Security & Data Ethics
15.1 HIPAA Privacy & Security Rules for Analysts 15.2 De-Identification Methodologies 15.3 Data Ethics, Audit Trails & Secondary Data Use
8.3 Parametric vs. Non-Parametric Tests
Key Takeaways Explain This Topic AI
Parametric tests (Independent t-test, Paired t-test, One-Way ANOVA, Two-Way ANOVA) assume continuous interval/ratio data, approximate normality of the sampling distribution, and homogeneity of variance (homoscedasticity), offering maximum statistical power when assumptions are satisfied.
Non-parametric tests (Mann-Whitney U, Wilcoxon Signed-Rank, Kruskal-Wallis, Friedman, Chi-Square, Fisher's Exact) make no restrictive distributional assumptions, analyzing rank-ordered or categorical data to provide robust inference for severely skewed healthcare metrics (e.g., costs, length of stay) and ordinal clinical scales.
An Independent Samples t-test compares means between two unrelated cohorts, while Welch's t-test adjusts degrees of freedom when group variances are unequal; a Paired Samples t-test evaluates paired observations or repeated pre/post measures on the same subjects.
One-Way ANOVA tests for differences among three or more group means using the omnibus F-statistic (MS_between / MS_within), requiring post-hoc pairwise adjustments (Tukey's HSD, Bonferroni) upon significance to identify specific group contrasts, while Two-Way ANOVA evaluates two simultaneous main factors and their interaction effect.
The Chi-Square ( χ 2 \chi^2 χ 2 ) Test of Independence evaluates associations between categorical variables in contingency tables ( χ 2 = ∑ ( O − E ) 2 / E \chi^2 = \sum (O-E)^2 / E χ 2 = ∑ ( O − E ) 2 / E , d f = ( r − 1 ) ( c − 1 ) df = (r-1)(c-1) df = ( r − 1 ) ( c − 1 ) ), requiring expected cell counts >= 5 in >= 80% of cells; Fisher's Exact Test provides exact hypergeometric probabilities for small sample 2x2 tables.
Last updated: August 2026
Parametric vs. Non-Parametric Tests
Health data analysts operate across diverse healthcare datasets ranging from physiological continuous monitors and billing dollar amounts to ordinal symptom rating scales and discrete categorical diagnostic codes. Selecting the correct statistical hypothesis test is critical: applying a test whose underlying mathematical assumptions are violated produces invalid p-values, misleading clinical conclusions, and flawed organizational policy. For the Certified Health Data Analyst (CHDA), mastering the dichotomy between parametric and non-parametric methods—and executing the appropriate test based on data scale, distribution shape, sample pairing, and group counts—is a core domain competency.
1. Core Theoretical Foundations: Parametric vs. Non-Parametric Paradigms +---------------------------------------------------------------------------------------------------+
- | THE PARAMETRIC VS. NON-PARAMETRIC DICHOTOMY |
- +-------------------------------------------------+-------------------------------------------------+
- | PARAMETRIC TESTS | NON-PARAMETRIC TESTS |
- | - Evaluates specific population PARAMETERS (\mu)| - Distribution-free; evaluates MEDIANS / RANKS |
- | - Assumes Normal distribution of residuals | - No assumption of normality |
- | - Assumes Homogeneity of Variance | - Robust against extreme skewness and outliers |
- | - Requires Continuous Interval / Ratio data | - Operates on Ordinal, Rank, or Nominal data |
- | - Higher statistical power when assumptions met | - Slightly lower power (~95% asymptotic eff.) |
- +-------------------------------------------------+-------------------------------------------------+
- Core Assumptions of Parametric Methods
Normality of Sampling Distribution: The continuous dependent variable (or residuals) is approximately normally distributed. Tested statistically via the Shapiro-Wilk test (for n < 50 n < 50 n < 50 ) or Kolmogorov-Smirnov test (for n ≥ 50 n \ge 50 n ≥ 50 ), or visually via Normal Q-Q Plots and histograms. (Note: Under the Central Limit Theorem, parametric tests are robust to moderate non-normality when n ≥ 30 n \ge 30 n ≥ 30 ).
Homogeneity of Variance (Homoscedasticity): The variance of the dependent variable across comparison groups is equal ( σ 1 2 = σ 2 2 = ⋯ = σ k 2 \sigma_1^2 = \sigma_2^2 = \dots = \sigma_k^2 σ 1 2 = σ 2 2 = ⋯ = σ k 2 ). Tested via Levene's Test for Equality of Variances or Bartlett's Test .
Scale of Measurement: The outcome variable is measured on a continuous Interval (e.g., temperature in Celsius) or Ratio scale (e.g., blood pressure in mmHg, financial costs in dollars, length of stay in days).
Independence of Observations: Individual data points must be independent of one another (unless using dedicated paired/repeated measures designs).
When Non-Parametric or Exact Tests Are Appropriate
Severely Skewed Healthcare Variables: Financial expenditures, ICU length of stay, and medication acquisition costs exhibit extreme right skewness with multi-million-dollar outliers that distort the sample mean x ˉ \bar{x} x ˉ .
Ordinal Clinical Staging and Survey Scales: Data captured on discrete ranked scales where numerical distances between categories are unequal or undefined:
Visual Analog Pain Scale ( 0 0 0 to 10 10 10 )
Patient Satisfaction Likert Scales ( 1 = Very Dissatisfied 1 = \text{Very Dissatisfied} 1 = Very Dissatisfied to 5 = Very Satisfied 5 = \text{Very Satisfied} 5 = Very Satisfied )
- Glasgow Coma Scale ( 3 3 3 to 15 15 15 )
- NYHA Heart Failure Functional Classes ( I , I I , I I I , I V I, II, III, IV I , II , III , I V )
- Cancer Staging ( 0 , I , I I , I I I , I V 0, I, II, III, IV 0 , I , II , III , I V )
Small Sample Sizes with Non-Normal Data ( n < 15 n < 15 n < 15 per group): Where the Central Limit Theorem cannot be invoked and normality cannot be demonstrated.
2. Parametric Statistical Tests in Healthcare Analytics +---------------------------------------------------------------------------------------------------+
- | PARAMETRIC TEST ARCHITECTURE |
- +-------------------+--------------------+--------------------+-------------------------------------+
- | INDEPENDENT t-TEST| PAIRED t-TEST | ONE-WAY ANOVA | TWO-WAY ANOVA |
- | - 2 Unrelated Grps| - 2 Matched / Pre- | - 3+ Independent | - 2 Simultaneous Independent Factors|
- | - df = n1 + n2 - 2| Post Measures | Groups (Omnibus) | - Evaluates Main Effects + |
- | - Compares Means | - df = n - 1 | - F = MS_B / MS_W | Interaction Effect (A x B) |
- +-------------------+--------------------+--------------------+-------------------------------------+
- 1. Independent Samples t-Test (Two-Sample t-Test)
Purpose: Compares the means of a continuous dependent variable between two independent, unrelated cohorts .
Clinical Example: Comparing the mean Inpatient Length of Stay (days) between patients undergoing laparoscopic cholecystectomy at Hospital A vs. Hospital B.
Formula (Equal Variances Assumed): t = x ˉ 1 − x ˉ 2 s p 1 n 1 + 1 n 2 , where s p = ( n 1 − 1 ) s 1 2 + ( n 2 − 1 ) s 2 2 n 1 + n 2 − 2 t = \frac{\bar{x}_1 - \bar{x}_2}{s_p \sqrt{\frac{1}{n_1} + \frac{1}{n_2}}}, \quad \text{where } s_p = \sqrt{\frac{(n_1 - 1)s_1^2 + (n_2 - 1)s_2^2}{n_1 + n_2 - 2}} t = s p n 1 1 + n 2 1 x ˉ 1 − x ˉ 2 , where s p = n 1 + n 2 − 2 ( n 1 − 1 ) s 1 2 + ( n 2 − 1 ) s 2 2 Degrees of Freedom: d f = n 1 + n 2 − 2 \text{Degrees of Freedom: } df = n_1 + n_2 - 2 Degrees of Freedom: df = n 1 + n 2 − 2
Welch's Unequal Variances t-Test: If Levene's test reveals unequal group variances ( p < 0.05 p < 0.05 p < 0.05 ), the standard pooled t-test produces inflated Type I errors. Analysts must utilize Welch's t-test , which modifies the standard error formula and uses the Welch-Satterthwaite equation to calculate fractional degrees of freedom.
2. Paired Samples t-Test (Dependent / Repeated Measures t-Test)
Purpose: Compares the means of two dependent, matched, or repeated measurements taken on the same individual subjects (or matched case-control pairs).
Clinical Example: Measuring resting Systolic Blood Pressure (mmHg) in n = 50 n = 50 n = 50 hypertensive patients immediately before initiating an ACE inhibitor (Baseline) and after 12 weeks of daily therapy (Post-treatment).
Mathematical Mechanics: Reduces paired observations into a single column of pairwise differences ( d i = x i , post − x i , pre d_i = x_{i,\text{post}} - x_{i,\text{pre}} d i = x i , post − x i , pre ): t = d ˉ s d / n t = \frac{\bar{d}}{s_d / \sqrt{n}} t = s d / n d ˉ where d ˉ \bar{d} d ˉ is the mean difference, s d s_d s d is the standard deviation of differences, and d f = n − 1 df = n - 1 df = n − 1 .
3. One-Way Analysis of Variance (ANOVA)
Purpose: Compares continuous means across three or more independent groups simultaneously, avoiding the severe Type I error inflation that would occur if multiple pairwise t-tests were executed.
Clinical Example: Comparing mean 6-month HbA1c reduction across k = 4 k = 4 k = 4 diabetic pharmacotherapy regimens: (1) Lifestyle/Diet alone, (2) Metformin monotherapy, (3) GLP-1 Receptor Agonist, and (4) Basal Insulin.
Hypotheses:
H 0 : μ 1 = μ 2 = μ 3 = ⋯ = μ k H_0: \mu_1 = \mu_2 = \mu_3 = \dots = \mu_k H 0 : μ 1 = μ 2 = μ 3 = ⋯ = μ k
H 1 : At least one group mean μ j differs from the others H_1: \text{At least one group mean } \mu_j \text{ differs from the others} H 1 : At least one group mean μ j differs from the others
The F F F -Statistic: Compares variance between the group means to variance within the groups: F = Mean Square Between ( M S between ) Mean Square Within ( M S within ) = S S between / ( k − 1 ) S S within / ( N − k ) F = \frac{\text{Mean Square Between } (MS_{\text{between}})}{\text{Mean Square Within } (MS_{\text{within}})} = \frac{SS_{\text{between}} / (k - 1)}{SS_{\text{within}} / (N - k)} F = Mean Square Within ( M S within ) Mean Square Between ( M S between ) = S S within / ( N − k ) S S between / ( k − 1 ) Degrees of Freedom: d f between = k − 1 , d f within = N − k \text{Degrees of Freedom: } df_{\text{between}} = k - 1, \quad df_{\text{within}} = N - k Degrees of Freedom: d f between = k − 1 , d f within = N − k
Omnibus Nature & Post-Hoc Pairwise Testing: A statistically significant ANOVA F F F -test ( p < 0.05 p < 0.05 p < 0.05 ) is omnibus —it indicates that the groups are not all equal, but does not specify which particular pairs differ. To identify specific pairwise differences while maintaining overall α = 0.05 \alpha = 0.05 α = 0.05 , analysts execute post-hoc tests :
Tukey's Honestly Significant Difference (HSD): Optimal for all pairwise comparisons when group sample sizes are equal.
Bonferroni / Sidak Correction: Conservative post-hoc adjustment for planned pairwise contrasts.
Dunnett's Test: Specifically compares multiple active treatment arms against a single reference control group.
4. Two-Way ANOVA (Factorial ANOVA)
Purpose: Evaluates the simultaneous effects of two categorical independent variables (factors) on a single continuous dependent variable, allowing evaluation of Main Effects and the Interaction Effect .
Clinical Example: Evaluating the effect of Medication Regimen (Factor A: Drug X vs. Drug Y vs. Placebo) and Cardiac Rehabilitation Intensity (Factor B: Standard vs. Intensive) on 12-month Left Ventricular Ejection Fraction (LVEF %).
The Interaction Effect ( A × B A \times B A × B ): Evaluates whether the effect of Factor A depends on the specific level of Factor B (e.g., Drug X only improves LVEF when paired with Intensive Rehabilitation).
3. Categorical Data Analysis: Chi-Square & Fisher's Exact Tests +---------------------------------------------------------------------------------------------------+
- | CATEGORICAL ASSOCIATION TESTS |
- +-------------------------------------------------+-------------------------------------------------+
- | CHI-SQUARE (\chi^2) TEST OF INDEPENDENCE | FISHER'S EXACT TEST |
- | - r x c Contingency Tables | - 2 x 2 Contingency Tables |
- | - Compares Observed (O) vs Expected (E) counts | - Exact hypergeometric probability |
| - Formula: \chi^2 = \sum (O - E)^2 / E | - Preferred for sparse 2x2 tables or when asymptotic assumptions fail |
- | - df = (r - 1) * (c - 1) | - Small pediatric, oncology, or rare cohorts |
- +-------------------------------------------------+-------------------------------------------------+
- Chi-Square ( χ 2 \chi^2 χ 2 ) Test of Independence
Purpose: Assesses whether a statistically significant association exists between two nominal or categorical variables presented in an r × c r \times c r × c contingency table.
Clinical Example: Evaluating whether 30-Day Hospital Readmission (Binary: Yes vs. No) is associated with Discharge Destination (Categorical: Home Self-Care vs. Home Health vs. Skilled Nursing Facility).
Test Statistic Formula: χ 2 = ∑ i = 1 r ∑ j = 1 c ( O i j − E i j ) 2 E i j \chi^2 = \sum_{i=1}^r \sum_{j=1}^c \frac{(O_{ij} - E_{ij})^2}{E_{ij}} χ 2 = i = 1 ∑ r j = 1 ∑ c E ij ( O ij − E ij ) 2 where O i j O_{ij} O ij is the observed cell count and E i j E_{ij} E ij is the expected cell count under H 0 H_0 H 0 .
Expected Frequency Formula: E i j = Row Total i × Column Total j Grand Total N E_{ij} = \frac{\text{Row Total}_i \times \text{Column Total}_j}{\text{Grand Total } N} E ij = Grand Total N Row Total i × Column Total j
Degrees of Freedom: d f = ( r − 1 ) × ( c − 1 ) df = (r - 1) \times (c - 1) df = ( r − 1 ) × ( c − 1 )
Assumptions of Chi-Square:
Random sampling and independent observations.
Categories must be mutually exclusive and exhaustive.
Sample Size Assumption: All expected cell frequencies must be ≥ 1 \ge 1 ≥ 1 , and at least 80% of cells must have expected frequencies E i j ≥ 5 E_{ij} \ge 5 E ij ≥ 5 .
Fisher's Exact Test
Purpose: An exact non-parametric test for 2 × 2 2 \times 2 2 × 2 contingency tables utilized when sample sizes are small and the Chi-Square assumption of expected cell frequencies ≥ 5 \ge 5 ≥ 5 is violated.
Mathematical Mechanics: Calculates the exact hypergeometric probability of observing the specific cell frequencies ( a , b , c , d a, b, c, d a , b , c , d ) given fixed marginal totals: P = ( a + b ) ! ( c + d ) ! ( a + c ) ! ( b + d ) ! a ! b ! c ! d ! N ! P = \frac{(a+b)! \, (c+d)! \, (a+c)! \, (b+d)!}{a! \, b! \, c! \, d! \, N!} P = a ! b ! c ! d ! N ! ( a + b )! ( c + d )! ( a + c )! ( b + d )!
Clinical Use Case: Evaluating surgical site infections between two rare pediatric neurosurgical approaches where total cases N = 25 N = 25 N = 25 and observed infections are 0 0 0 and 3 3 3 .
4. Non-Parametric Equivalents: The Complete Analytic Crosswalk
When continuous healthcare variables violate normality assumptions or when data is ordinal, analysts substitute parametric tests with their corresponding non-parametric rank-based equivalents . +---------------------------------------------------------------------------------------------------+
- | PARAMETRIC TO NON-PARAMETRIC MAPPING |
- +-------------------------------+-------------------------------+-----------------------------------+
- | ANALYTIC SCENARIO | PARAMETRIC TEST (Normality) | NON-PARAMETRIC EQUIVALENT (Ranks) |
- +-------------------------------+-------------------------------+-----------------------------------+
- | 2 Independent Groups | Independent Samples t-Test | MANN-WHITNEY U TEST (Wilcoxon) |
- | 2 Paired / Pre-Post Measures | Paired Samples t-Test | WILCOXON SIGNED-RANK TEST |
- | 3+ Independent Groups | One-Way ANOVA (F-Test) | KRUSKAL-WALLIS H TEST |
- | 3+ Repeated / Paired Measures | Repeated Measures ANOVA | FRIEDMAN TEST |
- | 2 Categorical Variables | Pearson Chi-Square (\chi^2) | FISHER'S EXACT TEST (Small n) |
- +-------------------------------+-------------------------------+-----------------------------------+
- 1. Mann-Whitney U Test (Wilcoxon Rank-Sum Test)
Parametric Equivalent: Independent Samples t-Test.
Mechanics: Combines all observations from both groups, ranks them in ascending order from 1 1 1 to N N N , and calculates the sum of ranks for each group. Tests whether the distribution medians differ.
Clinical Application: Comparing Emergency Department Length of Stay (hours, severely right-skewed) between patients presenting during Day Shift vs. Night Shift.
2. Wilcoxon Signed-Rank Test
Parametric Equivalent: Paired Samples t-Test.
Mechanics: Calculates pairwise differences ( d i = x post − x pre d_i = x_{\text{post}} - x_{\text{pre}} d i = x post − x pre ), drops zero differences, ranks the absolute values ∣ d i ∣ |d_i| ∣ d i ∣ from lowest to highest, attaches the original positive/negative signs to the ranks, and sums the ranks.
Clinical Application: Comparing patient-reported pain scores ( 0 0 0 to 10 10 10 Visual Analog Scale) measured on the same cohort of oncology patients immediately before and after palliative acupuncture.
3. Kruskal-Wallis H Test
Parametric Equivalent: One-Way ANOVA.
Mechanics: Extends the Mann-Whitney U concept to k ≥ 3 k \ge 3 k ≥ 3 independent groups. Ranks all N N N pooled observations and computes the H H H -statistic based on rank sums per group ( d f = k − 1 df = k - 1 df = k − 1 ).
Post-Hoc Testing: When Kruskal-Wallis is statistically significant ( p < 0.05 p < 0.05 p < 0.05 ), analysts perform Dunn's Post-Hoc Test with Bonferroni adjustment to identify specific pairwise differences.
Clinical Application: Comparing Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) patient satisfaction ratings ( 1 1 1 to 5 5 5 Likert scale) across 5 distinct regional health system clinics.
4. Friedman Test
Parametric Equivalent: Repeated Measures ANOVA.
Mechanics: Ranks observations across k ≥ 3 k \ge 3 k ≥ 3 repeated time points or conditions within each individual subject.
Clinical Application: Tracking Functional Independence Measure (FIM) motor scores in stroke rehabilitation patients across four sequential assessment intervals: Admission, Week 2, Week 4, and Discharge.
5. Step-by-Step Worked Chi-Square Calculation Example
Healthcare Scenario: A hospital quality analytics team evaluates whether implementing an "Enhanced Recovery After Surgery" (ERAS) multimodal clinical pathway significantly reduces 30-day all-cause readmissions among colorectal surgery patients compared to standard traditional post-operative care. The quality department tracks N = 400 N = 400 N = 400 total surgical discharges over 12 months.
Step 1: Formulate the Hypotheses
Null Hypothesis ( H 0 H_0 H 0 ): 30-Day Readmission is independent of the surgical care pathway (Discharge pathway and readmission status are unrelated).
Alternative Hypothesis ( H 1 H_1 H 1 ): 30-Day Readmission is dependent on the surgical care pathway (Readmission rates differ significantly between ERAS and Standard Care).
Significance Level: α = 0.05 \alpha = 0.05 α = 0.05 .
Step 2: Construct the 2 × 2 2 \times 2 2 × 2 Contingency Table of Observed Counts ( O i j O_{ij} O ij )
- Clinical Care Pathway Readmitted within 30 Days (Yes) Not Readmitted (No) Row Total ( R i R_i R i )
- ERAS Pathway 20 20 20 (Cell 1,1) 180 180 180 (Cell 1,2) R 1 = 200 R_1 = 200 R 1 = 200
- Standard Care 50 50 50 (Cell 2,1) 150 150 150 (Cell 2,2) R 2 = 200 R_2 = 200 R 2 = 200
Column Total ( C j C_j C j ) C 1 = 70 C_1 = 70 C 1 = 70 C 2 = 330 C_2 = 330 C 2 = 330 Grand Total N = 400 N = 400 N = 400
Step 3: Calculate Expected Frequencies ( E i j = R i × C j N E_{ij} = \frac{R_i \times C_j}{N} E ij = N R i × C j )
ERAS / Readmitted ( E 11 E_{11} E 11 ): E 11 = R 1 × C 1 N = 200 × 70 400 = 35.00 E_{11} = \frac{R_1 \times C_1}{N} = \frac{200 \times 70}{400} = \mathbf{35.00} E 11 = N R 1 × C 1 = 400 200 × 70 = 35.00
ERAS / Not Readmitted ( E 12 E_{12} E 12 ): E 12 = R 1 × C 2 N = 200 × 330 400 = 165.00 E_{12} = \frac{R_1 \times C_2}{N} = \frac{200 \times 330}{400} = \mathbf{165.00} E 12 = N R 1 × C 2 = 400 200 × 330 = 165.00
Standard / Readmitted ( E 21 E_{21} E 21 ): E 21 = R 2 × C 1 N = 200 × 70 400 = 35.00 E_{21} = \frac{R_2 \times C_1}{N} = \frac{200 \times 70}{400} = \mathbf{35.00} E 21 = N R 2 × C 1 = 400 200 × 70 = 35.00
Standard / Not Readmitted ( E 22 E_{22} E 22 ): E 22 = R 2 × C 2 N = 200 × 330 400 = 165.00 E_{22} = \frac{R_2 \times C_2}{N} = \frac{200 \times 330}{400} = \mathbf{165.00} E 22 = N R 2 × C 2 = 400 200 × 330 = 165.00
Assumption Check: All expected frequencies are 35.0 35.0 35.0 and 165.0 165.0 165.0 , all strictly ≥ 5 \ge 5 ≥ 5 . The Chi-Square assumption is satisfied.
Step 4: Calculate Cell Chi-Square Components ( ( O − E ) 2 E \frac{(O - E)^2}{E} E ( O − E ) 2 )
Cell Description Observed ( O O O ) Expected ( E E E ) Difference ( O − E O - E O − E ) ( O − E ) 2 (O - E)^2 ( O − E ) 2 Component ( O − E ) 2 E \frac{(O - E)^2}{E} E ( O − E ) 2
ERAS / Readmitted 20 20 20 35.0 35.0 35.0 − 15.0 -15.0 − 15.0 225.00 225.00 225.00 225.00 / 35.0 = 6.4286 225.00 / 35.0 = \mathbf{6.4286} 225.00/35.0 = 6.4286
ERAS / Not Readmitted 180 180 180 165.0 165.0 165.0 + 15.0 +15.0 + 15.0 225.00 225.00 225.00 225.00 / 165.0 = 1.3636 225.00 / 165.0 = \mathbf{1.3636} 225.00/165.0 = 1.3636
Standard / Readmitted 50 50 50 35.0 35.0 35.0 + 15.0 +15.0 + 15.0 225.00 225.00 225.00 225.00 / 35.0 = 6.4286 225.00 / 35.0 = \mathbf{6.4286} 225.00/35.0 = 6.4286
Standard / Not Readmitted 150 150 150 165.0 165.0 165.0 − 15.0 -15.0 − 15.0 225.00 225.00 225.00 225.00 / 165.0 = 1.3636 225.00 / 165.0 = \mathbf{1.3636} 225.00/165.0 = 1.3636
Step 5: Sum Components & Determine Critical Value χ 2 = 6.4286 + 1.3636 + 6.4286 + 1.3636 = 15.5844 ≈ 15.58 \chi^2 = 6.4286 + 1.3636 + 6.4286 + 1.3636 = \mathbf{15.5844} \approx 15.58 χ 2 = 6.4286 + 1.3636 + 6.4286 + 1.3636 = 15.5844 ≈ 15.58 Degrees of Freedom: d f = ( r − 1 ) × ( c − 1 ) = ( 2 − 1 ) × ( 2 − 1 ) = 1 × 1 = 1 \text{Degrees of Freedom: } df = (r - 1) \times (c - 1) = (2 - 1) \times (2 - 1) = 1 \times 1 = \mathbf{1} Degrees of Freedom: df = ( r − 1 ) × ( c − 1 ) = ( 2 − 1 ) × ( 2 − 1 ) = 1 × 1 = 1
Critical Value for d f = 1 , α = 0.05 df = 1, \alpha = 0.05 df = 1 , α = 0.05 : χ crit 2 = 3.841 \chi^2_{\text{crit}} = \mathbf{3.841} χ crit 2 = 3.841 .
Critical Value for d f = 1 , α = 0.001 df = 1, \alpha = 0.001 df = 1 , α = 0.001 : χ crit 2 = 10.828 \chi^2_{\text{crit}} = \mathbf{10.828} χ crit 2 = 10.828 .
Step 6: Statistical Decision & Clinical Interpretation
Statistical Decision: Because the calculated χ 2 = 15.58 \chi^2 = 15.58 χ 2 = 15.58 substantially exceeds the critical threshold of 3.841 3.841 3.841 (and exceeds 10.828 10.828 10.828 , yielding p < 0.001 p < 0.001 p < 0.001 ), we Reject H 0 H_0 H 0 at α = 0.05 \alpha = 0.05 α = 0.05 .
Clinical Conclusion: There is a statistically significant association between the clinical care pathway and 30-day readmissions. Colorectal surgery patients managed under the ERAS pathway experienced a significantly lower readmission rate ( 20 / 200 = 10.0 % 20/200 = 10.0\% 20/200 = 10.0% ) compared to standard care ( 50 / 200 = 25.0 % 50/200 = 25.0\% 50/200 = 25.0% ).
6. Master Decision Guide for Statistical Test Selection
Research Question / Analytics Objective Dependent Variable (Scale) Independent Variable (Groups / Factors) Parametric Test (Normal / Homogeneous) Non-Parametric Alternative (Non-Normal / Ordinal)
Compare average total cost between Medicare Advantage and Commercial plans Inpatient Total Cost (Continuous Ratio) Payer Type (2 Independent Groups) Independent Samples t-Test (or Welch's t-test) Mann-Whitney U Test (Wilcoxon Rank-Sum)
Compare patient systolic blood pressure before and after starting an ACE inhibitor Blood Pressure in mmHg (Continuous Ratio) Timepoint (2 Paired / Pre-Post Measures) Paired Samples t-Test Wilcoxon Signed-Rank Test
Compare mean length of stay across 4 different hospital surgical teams Length of Stay in Days (Continuous Ratio) Surgical Team (4 Independent Groups) One-Way ANOVA ( F F F -Test) followed by Tukey HSD Kruskal-Wallis H Test followed by Dunn's Test
Evaluate effect of Drug Type and Diet on 6-month LDL cholesterol reduction LDL Reduction in mg/dL (Continuous Ratio) 2 Factors: Drug (3 tiers) and Diet (2 tiers) Two-Way ANOVA (Main Effects + Interaction) Scheirer-Ray-Hare Test or Robust Regression
Determine if emergency room triage level (1-5) improves across 3 clinical shifts ESI Triage Level (Discrete Ordinal) Work Shift (3 Independent Groups) Invalid (Ordinal data violates parametric assumptions) Kruskal-Wallis H Test
Evaluate association between post-op infection (Yes/No) and diabetic status (Yes/No) Post-Op Infection (Binary Categorical) Diabetic Status (Binary Categorical) Chi-Square ( χ 2 \chi^2 χ 2 ) Test of Independence Fisher's Exact Test (often preferred for sparse 2x2 tables)
Assess change in pain score (0-10) before and after inpatient physical therapy Pain Score (Discrete Ordinal) Assessment Time (2 Paired Measures) Invalid (Ordinal scale) Wilcoxon Signed-Rank Test
Track functional mobility rank scores across 4 rehabilitation milestones Functional Mobility Rank (Ordinal) Timepoints (4 Repeated Measures) Repeated Measures ANOVA (if continuous) Friedman Test